Benicar and Antivert drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benicar (olmesartan medoxomil) and Antivert (meclizine hydrochloride). Common drug interactions include bone disorder among females and balance disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Benicar and Antivert. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.



On Jul, 09, 2026

71 people who take Benicar and Antivert together, and have interactions are studied.

Benicar and Antivert drug interactions.

What are the common drug interactions of Benicar and Antivert, by gender? *:

female:

  1. Bone disorder
  2. Congestive cardiomyopathy (weakening of heart muscle)
  3. Headache (pain in head)
  4. Multiple injuries
  5. Pain in extremity
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Arthralgia (joint pain)
  8. Atypical femur fracture
  9. Blood sodium decreased
  10. Carotid artery stenosis (narrowing of carotid artery)

male:

  1. Balance disorder
  2. Dyspnoea (difficult or laboured respiration)
  3. Headache (pain in head)
  4. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  5. Nausea (feeling of having an urge to vomit)
  6. Neuropathy peripheral (surface nerve damage)
  7. Vomiting
  8. Agitation (state of anxiety or nervous excitement)
  9. Alanine aminotransferase decreased
  10. Anxiety

What are the common drug interactions of Benicar and Antivert, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Aphasia (damage to the parts of the brain that control language)
  3. Cardiac failure congestive
  4. Carotid artery stenosis (narrowing of carotid artery)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Congestive cardiomyopathy (weakening of heart muscle)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Gait disturbance
  9. Hemiparesis (weakness on one side of the body)
  10. Hypoaesthesia (reduced sense of touch or sensation)

50-59:

  1. Accelerated hypertension (significant hypertension)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Carotid artery stenosis (narrowing of carotid artery)
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Diabetic nephropathy (diabetic kidney disease)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Fatigue (feeling of tiredness)
  9. Injection site bruising
  10. Injection site pain

60+:

  1. Pain
  2. Balance disorder
  3. Fatigue (feeling of tiredness)
  4. Urinary tract infection
  5. Weight decreased
  6. Anxiety
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Asthenia (weakness)
  9. Back pain
  10. Cataract (clouding of the lens inside the eye)

What are the existing conditions these people have? *

  1. Prostate Cancer: 11 people, 15.49%
  2. Metastases To Bone (cancer spreads to bone): 11 people, 15.49%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 11.27%
  4. Heart Rate Irregular: 5 people, 7.04%
  5. Renal Disorder (kidney disease): 4 people, 5.63%
  6. Pain: 4 people, 5.63%
  7. Hypersensitivity: 4 people, 5.63%

* Approximation only. Some reports may have incomplete information.

Do you take Benicar and Antivert?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benicar and Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benicar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil and meclizine hydrochloride (the active ingredients of Benicar and Antivert, respectively), and Benicar and Antivert (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: